| Net Cash Provided by (Used in) Operating Activities |
-555K |
USD |
-81.1% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
897K |
USD |
+45.8% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
-156K |
USD |
|
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
350M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
128M |
shares |
+19.5% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
138K |
USD |
+15.9% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
4.2M |
USD |
+108% |
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
4.2M |
USD |
+108% |
Q3 2025 |
Q3 2025 |
| Depreciation |
3.16K |
USD |
|
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
87.4K |
USD |
+31.7% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
4.2M |
USD |
+108% |
Q3 2025 |
Q3 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
14.3M |
USD |
+21.7% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
272K |
USD |
+27.4% |
Q1 2025 |
Q1 2025 |
| Amortization of Intangible Assets |
28.2K |
USD |
-74.7% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
321K |
USD |
-81.9% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
462K |
USD |
+417% |
Q1 2024 |
Q1 2024 |